相关临床试验
243
11 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1907
进行中（未招募）
1
0.4%
已完成
163
67.1%
尚未招募
10
4.1%
招募中
26
10.7%
暂停
2
0.8%
终止
9
3.7%
Unknown
21
8.6%
撤回
11
4.5%
暂无批准数据
- Researchers in Argentina reported that four of five hantavirus patients survived after receiving tocilizumab, a rheumatoid arthritis drug, compared to five deaths among patients who received only standard care. - The study represents the first use of tocilizumab in a compassionate use trial for hantavirus pulmonary syndrome, targeting the IL-6 inflammatory pathway that contributes to lung failure. - Multiple research teams are developing antibody treatments and vaccines for hantavirus, but limited funding and the virus's rarity have hindered progress despite mortality rates reaching 35-40%. - Recent cruise ship outbreak that killed three passengers has renewed attention to hantavirus research, with scientists hoping for increased investment in treatment development.
- The FDA intends to implement a black box warning on COVID-19 vaccines by the end of the year, according to sources familiar with the agency's plans. - The initiative is being led by Dr. Vinay Prasad, who claimed in an internal memo that 10 children died after COVID-19 vaccination, though no supporting data has been released. - Former FDA officials and public health experts have criticized the move as lacking scientific basis and transparency in the decision-making process. - Recent CDC data shows COVID-19 vaccines were 76% effective at preventing emergency visits in children aged 9 months to 4 years during the 2024-25 season.
- The University of the Sunshine Coast has developed and received regulatory approval for the world's first single-dose vaccine to protect koalas from chlamydia, a disease that causes up to half of koala deaths in wild populations. - Clinical trials demonstrated the vaccine reduces mortality from chlamydia by at least 65% and decreases the likelihood of symptomatic disease during breeding age in wild koala populations. - The vaccine targets Chlamydia pecorum's major outer membrane protein and offers three levels of protection: reducing infection, preventing disease progression, and potentially reversing existing symptoms. - With some wild koala colonies experiencing infection rates as high as 70%, this breakthrough represents a critical intervention for conserving Australia's endangered marsupial populations.
